HY2Care Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $4.67M

  • Investors
  • 7

HY2Care General Information

Description

Manufacturer of an injectable hydrogel designed to repair cartilage defects. The company's two-component injectable and bioresorbable hydrogel are composed of a mixture of natural polymer conjugates that cross-link in a mild enzymatic reaction, enabling clinicians to treat patients with functional repair of cartilage defects in the knee.

Contact Information

Website
www.hy2care.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Urmonderbaan 22
  • 6167 RD Geleen
  • Netherlands
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Urmonderbaan 22
  • 6167 RD Geleen
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HY2Care Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 27-Jan-2025 $4.67M In Progress Generating Revenue
7. Grant 23-Mar-2022 Completed Generating Revenue
6. Later Stage VC (Series A) 30-Apr-2019 Completed Generating Revenue
5. Angel (individual) 01-Jan-2017 Completed Generating Revenue
4. Grant 04-Aug-2016 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator 13-Apr-2015 $16.2K $16.2K Completed Generating Revenue
1. Grant Completed Startup
To view HY2Care’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HY2Care Patents

HY2Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4403195-A1 Kit of parts suitable for preparing a biocompatible polymeric hydrogel Pending 17-Jan-2023
CA-3088978-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Pending 18-Jan-2018
EP-3740525-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Active 18-Jan-2018
US-11414483-B2 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Active 18-Jan-2018
US-20200347125-A1 Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules Active 18-Jan-2018 C08J3/075
To view HY2Care’s complete patent history, request access »

HY2Care Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HY2Care Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Fund Venture Capital Minority
Brightlands Venture Partners Venture Capital Minority
ReumaNederland Corporation Minority
Horizon 2020 SME Instrument Government
Startupbootcamp VC-Backed Company Minority
You’re viewing 5 of 7 investors. Get the full list »

HY2Care FAQs

  • When was HY2Care founded?

    HY2Care was founded in 2014.

  • Where is HY2Care headquartered?

    HY2Care is headquartered in Geleen, Netherlands.

  • What is the size of HY2Care?

    HY2Care has 12 total employees.

  • What industry is HY2Care in?

    HY2Care’s primary industry is Other Devices and Supplies.

  • Is HY2Care a private or public company?

    HY2Care is a Private company.

  • What is HY2Care’s current revenue?

    The current revenue for HY2Care is .

  • How much funding has HY2Care raised over time?

    HY2Care has raised $8.84M.

  • Who are HY2Care’s investors?

    European Innovation Council Fund, Brightlands Venture Partners, ReumaNederland, Horizon 2020 SME Instrument, and Startupbootcamp are 5 of 7 investors who have invested in HY2Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »